Karyopharm Therapeutics SEC Filings https://investors.karyopharm.com/ Karyopharm Therapeutics SEC Filings en 8-K: Report of unscheduled material events or corporate event https://investors.karyopharm.com/sec-filings/sec-filing/8-k/0001193125-19-176471 Karyopharm Therapeutics Wed, 19 Jun 2019 16:10:11 -0400 Karyopharm Therapeutics SEC Filings 12076 8-K: Report of unscheduled material events or corporate event https://investors.karyopharm.com/sec-filings/sec-filing/8-k/0001193125-19-173040 Karyopharm Therapeutics Fri, 14 Jun 2019 07:36:08 -0400 Karyopharm Therapeutics SEC Filings 12066 8-K: Report of unscheduled material events or corporate event https://investors.karyopharm.com/sec-filings/sec-filing/8-k/0001193125-19-168167 Karyopharm Therapeutics Fri, 07 Jun 2019 16:10:45 -0400 Karyopharm Therapeutics SEC Filings 12056 4: Statement of changes in beneficial ownership of securities https://investors.karyopharm.com/sec-filings/sec-filing/4/0001209191-19-035378 Karyopharm Therapeutics Fri, 07 Jun 2019 09:03:22 -0400 Karyopharm Therapeutics SEC Filings 12051 4: Statement of changes in beneficial ownership of securities https://investors.karyopharm.com/sec-filings/sec-filing/4/0001209191-19-035376 Karyopharm Therapeutics Fri, 07 Jun 2019 09:01:22 -0400 Karyopharm Therapeutics SEC Filings 12046 4: Statement of changes in beneficial ownership of securities https://investors.karyopharm.com/sec-filings/sec-filing/4/0001209191-19-035377 Karyopharm Therapeutics Fri, 07 Jun 2019 09:01:22 -0400 Karyopharm Therapeutics SEC Filings 12041 4: Statement of changes in beneficial ownership of securities https://investors.karyopharm.com/sec-filings/sec-filing/4/0001209191-19-035373 Karyopharm Therapeutics Fri, 07 Jun 2019 08:57:23 -0400 Karyopharm Therapeutics SEC Filings 12036 4: Statement of changes in beneficial ownership of securities https://investors.karyopharm.com/sec-filings/sec-filing/4/0001209191-19-035374 Karyopharm Therapeutics Fri, 07 Jun 2019 08:57:22 -0400 Karyopharm Therapeutics SEC Filings 12026 4: Statement of changes in beneficial ownership of securities https://investors.karyopharm.com/sec-filings/sec-filing/4/0001209191-19-035375 Karyopharm Therapeutics Fri, 07 Jun 2019 08:57:22 -0400 Karyopharm Therapeutics SEC Filings 12031 424B5: Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3 https://investors.karyopharm.com/sec-filings/sec-filing/424b5/0001193125-19-144258 Karyopharm Therapeutics Fri, 10 May 2019 16:24:43 -0400 Karyopharm Therapeutics SEC Filings 11986